Search
Now showing items 1-4 of 4
Treatment of ocular hypertension and glaucoma with dopamine antagonists
(United States. Patent and Trademark Office, 1988-09-20)
Aqueous humor formation and intraocular pressure in mammals having ocular hypertension or glaucoma may be reduced by topically administering to a hypertensive eye an ophthalmologically acceptable amount of certain dopamine ...
Compositions and methods of lowering intraocular pressure in the hypertensive mammalian eye
(United States. Patent and Trademark Office, 1984-07-10)
Compositions for treating open-angle glaucoma comprising N,N-dimethylaminoethyl carbamate and method of treating ocular hypertension by topically administering such compound to the hypertensive eye.
Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma
(United States. Patent and Trademark Office, 1985-06-04)
Antiglaucoma compositions that contain enriched R-(+)-1-tert-butylamino-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-prop anol compared to the S-(-)-isomer and the ophthalmologically acceptable acid addition salts thereof ...
Method and ophthalmic composition for treating ocular hypertension and glaucoma with butyrophenones
(United States. Patent and Trademark Office, 1986-01-21)
Aqueous humor formation and intraocular pressure in mammals having ocular hypertension or glaucoma may be reduced by topically administering to a hypertensive eye an ophthalmologically acceptable amount of a dopamine ...